1.71 USD
▲-0.06+4.91%
盘后 1.60 -1.84%
2026-08-03
市值
$2.54M
市盈率
—
EPS
-71.49
股息率
—
52 周区间
1.43 – 524.00
成交量
107.67K
Beta
-1.18
目标价
—
52W 低 1.4352W 高 524.00
价格走势
公司简介
Clearmind Medicine Inc., a clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. The company develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression. It develops MEAI compound for the treatment of alcohol use disorder, obesity, and metabolic disorders, as well as an alcohol substitute consumer product; a...